First human trials of CRISPR outside China have been declared successful

A pair of biotech companies have successfully eliminated symptoms from two patients with different blood diseases

The growing list of successful treatments by CRISPR technology to treat various diseases has infused hope in revolutionary medical technology to be the next big thing. Preliminary data from the first successful human trial points to the new era human gene editing is upon us. CRISPR Therapeutics and Vertex Pharmaceuticals announced the results recently.

This is being considered a significant development since this is the first successful human trial outside China. Back in November 2018, He Jiankui, a Chinese biophysicist, rocked the Medical World with his revelation announcing that he had genetically modified the DNA of the twin baby girls before bringing them into the World by using the CRISPR tool.

Chinese Scientists were back in the news again recently with the claim of using the CRISPR tool for trying to treat an HIV & Cancer infected male. And the results were promising. The patient was apparently cured of Cancer but the HIV virus remained. Both these reports were seen with skepticism though, as is the case with most news coming out of the government censored media in the country.